MassMutual Private Wealth & Trust’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Buy
4,135
+330
+9% +$29.5K 0.01% 330
2026
Q1
$273K Sell
3,805
-944
-20% -$72.7K 0.01% 390
2025
Q4
$377K Buy
4,749
+759
+19% +$59.8K 0.01% 343
2025
Q3
$301K Sell
3,990
-754
-16% -$51.7K 0.01% 379
2025
Q2
$327K Buy
4,744
+25
+0.5% +$1.64K 0.01% 375
2025
Q1
$320K Buy
4,719
+1,381
+41% +$82.6K 0.01% 368
2024
Q4
$150K Sell
3,338
-65,738
-95% -$3.69M ﹤0.01% 496
2024
Q3
$4.34M Sell
69,076
-7,076
-9% -$413K 0.12% 154
2024
Q2
$4.5M Sell
76,152
-56,700
-43% -$3.55M 0.14% 139
2024
Q1
$10.6M Buy
132,852
+3,456
+3% +$264K 0.33% 74
2023
Q4
$10.2M Sell
129,396
-9,369
-7% -$667K 0.34% 72
2023
Q3
$9.69M Sell
138,765
-2,769
-2% -$196K 0.36% 69
2023
Q2
$9.78M Sell
141,534
-3,438
-2% -$245K 0.35% 73
2023
Q1
$10.8M Buy
144,972
+2,745
+2% +$230K 0.41% 68
2022
Q4
$13.3M Buy
142,227
+7,067
+5% +$682K 0.55% 47
2022
Q3
$12.9M Buy
135,160
+848
+0.6% +$83.9K 0.58% 43
2022
Q2
$12.4M Buy
134,312
+11,670
+10% +$1.14M 0.54% 48
2022
Q1
$12.4M Sell
122,642
-851
-0.7% -$89.4K 0.47% 53
2021
Q4
$12.7M Buy
123,493
+3,205
+3% +$296K 0.47% 52
2021
Q3
$10.2M Buy
120,288
+1,280
+1% +$107K 0.42% 61
2021
Q2
$9.93M Buy
119,008
+3,066
+3% +$251K 0.42% 55
2021
Q1
$8.72M Buy
115,942
+4,279
+4% +$312K 0.41% 64
2020
Q4
$7.63M Sell
111,663
-9,905
-8% -$644K 0.39% 66
2020
Q3
$7.1M Buy
121,568
+1,581
+1% +$98.4K 0.42% 63
2020
Q2
$7.8M Buy
119,987
+12,717
+12% +$801K 0.5% 49
2020
Q1
$6.36M Buy
107,270
+1,204
+1% +$80.4K 0.51% 50
2019
Q4
$7.88M Buy
106,066
+2,562
+2% +$180K 0.49% 52
2019
Q3
$6.53M Buy
103,504
+5,238
+5% +$310K 0.44% 59
2019
Q2
$5.36M Buy
98,266
+67,439
+219% +$3.63M 0.37% 71
2019
Q1
$1.66M Buy
30,827
+7,517
+32% +$464K 0.12% 163
2018
Q4
$1.53M Sell
23,310
-145
-0.6% -$10.8K 0.13% 151
2018
Q3
$1.85M Buy
23,455
+106
+0.5% +$7.58K 0.14% 145
2018
Q2
$1.5M Sell
23,349
-16,241
-41% -$1.07M 0.12% 153
2018
Q1
$2.46M Sell
39,590
-3,826
-9% -$275K 0.2% 115
2017
Q4
$3.15M Sell
43,416
-12,450
-22% -$905K 0.26% 101
2017
Q3
$4.54M Buy
55,866
+2,025
+4% +$160K 0.38% 74
2017
Q2
$4.33M Buy
53,841
+1,398
+3% +$110K 0.39% 73
2017
Q1
$4.12M Buy
52,443
+10,028
+24% +$801K 0.39% 77
2016
Q4
$3.35M Buy
+42,415
New +$3.43M 0.41% 72
2016
Q2
$3.09M Sell
32,234
-19,934
-38% -$1.99M 0.39% 75
2016
Q1
$5.41M Buy
52,168
+713
+1% +$69.3K 0.73% 29
2015
Q4
$5.03M Buy
51,455
+22,472
+78% +$2.2M 0.72% 32
2015
Q3
$2.31M Buy
28,983
+10,342
+55% +$1.09M 0.49% 54
2015
Q2
$1.4M Sell
18,641
-19,870
-52% -$2.03M 0.31% 79
2015
Q1
$3.97M Buy
38,511
+23,517
+157% +$2.38M 0.66% 39
2014
Q4
$1.44M Sell
14,994
-13,989
-48% -$1.23M 0.47% 61
2014
Q3
$2.31M Buy
28,983
+28,519
+6,146% +$2.25M 0.46% 57
2014
Q2
$35K Buy
464
+113
+32% +$8.54K 0.01% 253
2014
Q1
$26.3K Buy
351
+1
+0.3% +$71 0.02% 248
2013
Q4
$25.1K Buy
+350
New +$22.5K 0.02% 230

Other funds holding CVS

MassMutual Private Wealth & Trust's CVS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its CVS Health (CVS) stake by 8.7% in Q2 2026, buying an estimated $29.5K and bringing the position to 4,135 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #330.

MassMutual Private Wealth & Trust first reported a position in CVS in Q4 2013 and has held it in 50 quarters since. The position peaked at $13.3M in Q4 2022. 997 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • MassMutual Private Wealth & Trust held 4,135 shares of CVS Health worth $428K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 330 CVS Health shares in Q2 2026, an estimated $29.5K.
  • CVS Health made up 0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #330 holding.
  • MassMutual Private Wealth & Trust first reported a position in CVS Health in Q4 2013 and has held it in 50 quarters since.
  • MassMutual Private Wealth & Trust's CVS Health position peaked at $13.3M in Q4 2022.
  • 997 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.